Export to Word
(http://www.niehs.nih.gov//portfolio/index.cfm?do=portfolio.grantdetail&&grant_number=R21ES033748&format=word)
| Principal Investigator: Laiosa, Michael D | |
|---|---|
| Institute Receiving Award | University Of Wisconsin Milwaukee |
| Location | Milwaukee, WI |
| Grant Number | R21ES033748 |
| Funding Organization | National Institute of Environmental Health Sciences |
| Award Funding Period | 10 Dec 2021 to 30 Nov 2024 |
| DESCRIPTION (provided by applicant): | The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor and global environmental sensor responsive to exogenous and endogenous microenvironmental ligands that we propose plays a central role coordinating the metabolic state of hematopoietic stem and progenitor cells. The choice made by hematopoietic stem cells between remaining quiescent and undergoing self-renewal, versus proliferating and differentiating into a lineage-restricted progenitor cell, is based on the balance of signals that promote catabolic versus anabolic metabolic activities. Catabolism is defined by recycling of organelles and proteins for self- renewal and quiescence, whereas anabolic production of energy and nutrients drives proliferation and differentiation. Hence, the fundamental question that will drive this and subsequent studies is what is the physiological role for the AHR on the balance of catabolic versus anabolic metabolism during hematopoiesis? The Long-term goal of our team is to uncover the mechanisms by which the AHR tunes the cellular metabolic state during the transition from hematopoietic stem cell to effector immune cell in response to microenvironmental stimuli. In pursuit of our goal, the objective of this high risk – high reward R21 proposal is to identify the role for the AHR on global regulation of mitochondria in hematopoietic stem and lineage-biased progenitor cells. The overarching hypothesis is that the AHR is a central regulator of metabolism in hematopoietic and immune system progenitors. The scientific premise that the AHR is a central regulator of metabolism is grounded, in part, on our exciting preliminary data that show: (1) the number of mitochondria in hematopoietic stem cells is specifically regulated by the AHR; and (2) the AHR is required for maximal oxidative burst in hematopoietic progenitors. The three specific aims employed to interrogate the overarching hypothesis are: Aim 1: Determine the AHR signaling thresholds required for mitochondria biogenesis during hematopoiesis. Aim 2: Identify the contribution of AHR-dependent signaling on anabolic activity of hematopoietic progenitors. Aim 3: Establish the AHR-dependent signaling thresholds required for maintaining catabolic activities in hematopoietic stem cells. This proposal is significant because it will for the first time identify a physiological role for the AHR in the balance of catabolic vs anabolic activities, thereby regulating metabolism of HSC and lineage-biased immune cell progenitors. This proposal is highly innovative as it represents a substantive departure from the status quo by linking the mechanism of hematopoietic regulation by the AHR to the metabolic drivers of quiescence, proliferation and differentiation. An expected outcome from these studies will be real-time visualization of mitochondria homeostasis dependent on AHR activity in hematopoietic stem and progenitor cells. The positive impact of the proposed work will be new avenues for treatment of hematological diseases caused by metabolic and mitochondrial dysfunction. |
| Science Code(s)/Area of Science(s) |
Primary: 52 - Immunology/Immunotoxicology Secondary: 03 - Carcinogenesis/Cell Transformation |
| Publications | No publications associated with this grant |
| Program Officer | Michael Humble |